Mouse strain differences in immobility and in sensitivity to antidepressants have been observed in the forced swimming test (FST) and the tail suspension test (TST). However, the neurotransmitter systems and neural substrates that contribute to these differences remain unknown. To investigate the role of the hippocampal serotonin transporter (5-HTT), we measured baseline immobility and the immobility responses to fluoxetine (FLX) in the FST and the TST in male CD-1, C57BL/6, DBA and BALB/c mice. We observed strain differences in baseline immobility time, with CD-1 mice showing the longest and DBA mice showing the shortest. In contrast, DBA and BALB/c mice showed the highest sensitivity to FLX, whereas CD-1 and C57BL/6 mice showed the lowest sensitivity. Also we found strain differences in both the total 5-HTT protein level and the membrane-bound 5-HTT level (estimated by V max ) as follows: DBA > BALB/c > CD-1 = C57BL/6. The uptake efficiency of the membranebound 5-HTT (estimated by 1/K m ) was highest in DBA and BALB/c mice and lowest in CD-1 and C57BL/6 mice. A correlation analysis of subregions within the hippocampus revealed that immobility time was negatively correlated with V max and positively correlated with K m in the hippocampus. Therefore a higher uptake capacity of the membrane-bound 5-HTT in the hippocampus was associated with lower baseline immobility and greater sensitivity to FLX. These results suggest that alterations in hippocampal 5-HTT activity may contribute to mouse strain differences in the FST and the TST.
Introduction
Depression is the most prevalent psychiatric disorder and ranks among the top five leading causes of disability worldwide (Kessler et al., 2003; Berton and Nestler, 2006; Krishnan and Nestler, 2008) . The disease has been modeled in rodents, especially in mice (Cryan and Slattery, 2007; Pollak et al., 2010; Yan et al., 2010) , to either provide a means for improving current therapeutic regimen and screening for putative antidepressant activity, or to foster theories related to the etiology of depression to be explored. Over the years, many rodent strains have been developed and used for various studies, potentially leading to variations among strains due to genetic impact on resulting phenotypes.
Mouse strain differences have been observed in neuroanatomical development (Wainwright and Deeks, 1984; Crusio et al., 1990; Livy and Wahlsten, 1991) , electrophysiological traits (Bampton et al., 1999) , and pharmacological responses to neurological compounds, especially antidepressants (Seale et al., 1984; Miner and Collins, 1989; Tolliver and Carney, 1994; Miner, 1997; Homanics et al., 1999; Lucki et al., 2001; David et al., 2003; Ripoll et al., 2003; Petit-Demouliere et al., 2005; Sugimoto et al., 2011; Can et al., 2013; O'Neill and Gu, 2013) . Furthermore, behavioral tasks, especially those commonly used in studies of depression, are significantly affected by the genetic variations among different strains Logue et al., 1997; Owen et al., 1997; Paylor and Crawley, 1997; Stiedl et al., 1999; Võikar et al., 2001; Pothion et al., 2004; Petit-Demouliere et al., 2005; Sugimoto et al., 2008) . However, specific neurotransmitter systems and neural substrates mediating the strain differences are not yet known.
Serotonin (5-HT) neurotransmitter system, especially 5-HT transporter (5-HTT), has been extensively studied in the pathophysiology and treatment of depression. Recently a functional polymorphism in the human 5-HTT gene promoter (the 5-HTT gene-linked polymorphic region, 5-HTTLPR) known to regulate 5-HTT expression and activity was linked to differential susceptibilities to depression (Caspi et al., 2003; Daniele et al., 2011) . 5-HTTLPR was also associated with antidepressant responses in a race-dependent manner, serving as a predictor of antidepressant efficacy in Caucasians, but not in Asians. This again indicates that genetic variation can influence the response to antidepressants (Porcelli et al., 2012) . The hippocampus has been identified as a key brain structure underlying the interaction between the 5-HTT gene variation and stress, and this association shows hippocampal subregion specificity (Carola et al., 2008; Carola and Gross, 2012) . Based on these findings, we hypothesize that differences in the hippocampal 5-HTT (1) contribute to mouse strain variations in behavioral tests commonly employed to study depression, and (2) may influence responses to the most prevalent antidepressants.
Four mouse strains, CD-1, C57BL/6, DBA, and BALB/c, were chosen for study based on (1) their reported strain differences in specific behavioral tasks Ripoll et al., 2003; Sugimoto et al., 2008 Sugimoto et al., , 2011 , (2) their prevailing use in psychopharmacological studies (Adriani et al., 2002; Ledesma and Aragon, 2012; Tang et al., 2013) , and (3) the frequency with which their genetic background is employed in transgenic lines with altered psychological behaviors (Cryan and Mombereau, 2004; Kim et al., 2011; Horiuchi et al., 2013; Yadav et al., 2013) . In the present study, the four mouse strains were used to examine immobility responses at baseline and following fluoxetine (FLX) treatment in both the forced swimming test (FST) and the tail suspension test (TST). The rationales to measure immobility responses are: (1) immobility mimics behavioral despair, which is a core endophenotype of clinical depression, and significant reduction in immobility has been commonly used as a benchmark to evaluate whether mice have developed depression (Zhao et al., 2008; Tang et al., 2013 Tang et al., , 2014 ; (2) immobility responses to commonly used antidepressants have been utilized to screen for drugs with more promising therapeutic efficacy. Following the behavioral tests, we measured 5-HTT protein expression and synaptosomal 5-HT uptake in the three main subregions of the hippocampus -the CA1, CA3 and dente gyrus (DG) -and analyzed their relationship with the observed behavioral responses.
Method

Animals
Male CD-1, C57BL/6, DBA, and BALB/c mice (10-12 wk old) were used. They were housed in a temperature (21 ± 1°C) and humidity (55 ± 2%) controlled room with a 12 h light-dark cycle (lights on at 08:00 hours). Animals were given free access to food and water all the time.
Mice used in the laboratory are commonly housed in groups of 3-20. However, group housing can result in the formation of social hierarchies. The stress associated with a lower social status makes the animals prone to develop depressive phenotypes, especially in males (Berton et al., 2006; Miczek et al., 2008) . These changes consequently influence the behavioral, neuroendocrine, neurochemical, and neurobiological responses to later stressors compared to their counterparts living in isolation (Audet and Anisman, 2010; Audet et al., 2011; McQuaid et al., 2012 McQuaid et al., , 2013a . To minimize any group housing effects, the mice used in our study were all individually housed for 2 wk prior to the experiments.
All experimental procedures were carried out in accordance with the guidelines for the humane care and use of laboratory animals set by the National Institute of Health in the United States and approved by the Institutional Animal Care and Use Committee at China Medical University.
Drug treatment
FLX-HCl, a selective 5-HT reuptake inhibitor (SSRI), was purchased from Sigma (USA). A dose range of the drug (1-20 mg/kg) covering the reported doses with efficacious antidepressant action Tang et al., 2013) was tested in the four mouse strains (n = 7/dose) in the locomotion test, FST and TST. FLX was dissolved in saline and given i.p. to the mice 30 min prior to the test in a volume of 5 ml/kg. Control animals were received saline in a volume of 5 ml/kg.
Measurement of locomotion
Spontaneous locomotor activity was measured in a closed transparent plastic arena (30 × 25 × 20 cm) consisting of 30 squares (5 cm × 5 cm each), which was connected to the SMART video tracking system (Panlab). The animals were allowed to acclimatize to the testing environment for 3 min prior to the actual recording. Locomotor activity was video recorded for a period of 10 min, and the total number of squares crossed horizontally by the animal was analyzed by the video tracking system.
FST
The test was performed based on the procedure described by Porsolt et al. (1977) with a few modifications. Mice were placed individually for 6 min into a plastic cylinder (height = 45 cm, diameter = 19 cm) containing water (height = 23 cm), maintained at 23 ± 1°C, and were scored for immobility during the last 4 min. Immobility was defined as the absence of active, escape-oriented behaviors, with only small movements to keep the head above water.
TST
The test was performed similar to that described by Steru et al. (1985) . Mice were individually suspended from the edge of a shelf 60 cm above the ground by adhesive tape placed over 1 cm from the tip of the tail. Mice were hung for 6 min, and were scored for immobility during the last 4 min. Immobility was defined as motionless without any agitation.
Dissection of hippocampal subregions
For each mouse strain, a separate group of mice (n = 14: 7 for the detection of 5-HTT protein expression level; 7 for the detection of synaptosomal [
3 H]5-HT uptake) that did not undergo behavioral tests was used. Mice were sacrificed by cervical dislocation and subsequent decapitation. Hippocampi were removed and dissected along the visible boundaries of the DG to yield the CA1, CA3, and DG (Lein et al., 2004 ), and each subregion was then weighed.
Western-blot of 5-HTT
Each dissected hippocampal subregion was homogenized in ice-cold lysis buffer (0.1% SDS, 1% Triton-100, 10 mM Hepes, 5 mM NaF, 0.25 M sucrose, pH 7.4) to prepare the cell lysate. Protein concentration was measured using the Bradford method (Bradford, 1976) , with bovine albumin as the standard. Each sample containing 100 μg of protein was loaded into 12% polyacrylamide gel, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, USA) overnight. The membrane was blocked with 5% milk in Tris-buffered saline with Tween-20 (TBS-T) for 2 h at room temperature. A goat anti-5-HTT polyclonal antibody (1:300, Santa Cruz) was incubated with the membrane for 4 h at room temperature. The membrane was washed once for 30 min and twice for 20 min with TBS-T, and incubated with a horseradish peroxidaseconjugated anti-goat IgG secondary antibody (1:500, Santa Cruz) for 2 h at room temperature. After the same washing steps, the specific immunoreactive staining was visualized by enhanced chemiluminescence (ECL) detection reagents (Sigma, USA), and captured by Tanon -4200 gel imaging system (Tanon Science, China). β-actin, a housekeeping protein, was detected with polyclonal rabbit antibody (1:1000, Santa Cruz) and secondary antirabbit antibody (1:1000, Santa Cruz). 5-HTT was revealed as a band of 70 KDa, β-actin as a band of 42 KDa. Band density was analyzed with GIS image analysis software (Tanon Science, China). To eliminate possible variations in the efficiency of protein extractions and sample loading, β-actin was used as an internal control. Hence, the expression level of 5-HTT was normalized to its corresponding β-actin level in each sample.
Synaptosomal [ 3 H]5-HT uptake
Each dissected hippocampal subregion was transferred into 15 volumes of ice-cold 0.32 M sucrose (pH 7.4, buffered with 5 mM Hepes) and homogenized at 800 r/min for 30 s. The homogenates were centrifuged at 1000 g (10 min, 4°C). The supernatants were then centrifuged at 17 000 g (20 min, 4°C). The resulting pellets were re-suspended in incubation buffer (130 mM NaCl, 2.6 mM KCl, 1.2 mM MgSO 4 , 1.0 mM KH 2 PO4, 1.3 mM CaCl 2 , 25 mM NaHCO 3 , 10 mM glucose, 0.05 mM EDTA, 0.1 mM ascorbic acid, 100 μM pargyline, pH 7.4) to a final protein concentration of 1-2 mg/ml. Protein concentration was measured using the Bradford method (Bradford, 1976) . 5-HT uptake was measured using six different concentrations of [ of incubation buffer for 5 min at 37°C. Thirty microliters of the synaptosomal suspension were added to each tube and incubated for 10 min at 37°C with gentle agitation. The reaction was terminated by immersing the tubes in ice water, followed by rapid filtration through Whatman GF/B filters. The filters were washed with incubation buffer and the radioactivity trapped on the filters was counted using a Packard 1900 TR liquid scintillation analyzer (Biostad). Specific [ 3 H]5-HT uptake was defined as the difference between the total uptake at 37°C and the uptake in the presence of 0.1 mM FLX at 0°C, and expressed as pmol/mg protein/min. The data were fitted to a Michaelis-Menten equation to determine the parameters of 5-HT saturation kinetics: V max and K m , which are the maximal amount and uptake efficiency of the membrane-bound 5-HTT, respectively.
Statistical analysis
Locomotion and immobility time were analyzed across the mouse strains using one-way ANOVA. The effects of FLX on locomotion and immobility time were determined across the strains using two-way ANOVA with two variables (Treatment and Strain). Protein expression of 5-HTT, V max and K m were analyzed using two-way ANOVA with two variables (Hippocampal subregion and Strain). Bonferroni correction factors were used for simple effects and post-hoc tests. The level of significance was p < 0.05. Values are expressed as mean ± S.E.M.
Correlations were evaluated by the Pearson test, and r 2 value of 0.9 was used as the cut-off point for statistical significance. All data used for correlation analyses were averaged data.
Results
No strain differences in baseline locomotion and in FLX's effects on locomotion
No differences in locomotion were found among the four mouse strains at the baseline (F 3,24 = 1.361, p > 0.05; n = 7/group) (Fig. 1a) . Following FLX treatment, two-way ANOVA did not show any interactions between treatment and strain on locomotion (F 15,144 = 0.57, p > 0.05; n = 7/group). Five different doses of FLX failed to affect locomotion compared to saline-treated controls in each mouse strain (Strain effect: F 3,144 = 0.44, p > 0.05; n = 7/group) ( Fig. 1b-e ).
Strain differences in immobility and in sensitivity to FLX in the FST
Baseline immobility was significantly different between the four mouse strains in the FST (F 3,24 = 10.041, p < 0.01; n = 7/group), post-hoc analysis indicated that the immobility times exhibited by BALB/c and DBA mice were significantly shorter than those exhibited by CD-1 and C57BL/6 mice ( Fig. 2a) . Following FLX treatment, twoway ANOVA revealed a Treatment x Strains interaction (F 15,144 = 6.31, p < 0.05; n = 7/group), with both significant Treatment effect [F 5,144 = 10.16, p < 0.05] and significant Strain effect (F 3,144 = 7.04, p < 0.05). Subsequent simple effects indicated that FLX significantly reduced immobility time in all strains but with distinct sensitivities (Fig. 2b-e) . CD-1 and C57BL/6 mice responded to FLX at doses of 5.0, and 10.0 mg/kg, respectively (Fig. 2b , c), DBA and BALB/c mice were more sensitive and responded to lower doses FLX (1.25 mg/kg) ( Fig. 2d , e).
Strain differences in immobility and in sensitivity to FLX in the TST
At baseline, strain differences in immobility were found in the TST (F 3,24 = 18.764, p < 0.01; n = 7/group). Post-hoc analysis indicated that the immobility times of CD-1 and C57BL/6 mice were significantly longer than those Locomotion was determined as number of square crossings over 10 min at baseline and following five different doses of fluoxetine (FLX) treatment in the four mouse strains (n = 7/group). One-way ANOVA did not find any differences in basal locomotion among the strains. Two-way ANOVA did not detect any differences in FLX's effects on locomotion among the strains. . Immobility and effects of fluoxetine (FLX) on immobility in the forced swim test. A significant strain difference in basal immobility was detected (n = 7/group). *p < 0.05 vs. CD-1 mice, # p < 0.05 vs. C57BL/6 mice, by post-hoc analysis following one-way ANOVA. FLX reduced the immobility time differently among the four mouse strains (n = 7/group). *p < 0.05 vs. corresponding saline-treated controls, by simple effects analysis after a significant two-way interaction in the overall ANOVA.
of BALB/c and DBA mice (Fig. 3a) . Following FLX treatment, a two-way interaction on immobility was detected (Treatment x Strains: F 15,144 = 7.97, p < 0.05; n = 7/group, with a significant Treatment effect (F 5,144 = 9.01, p < 0.05) and a significant Strain effect (F 3,144 = 8.33, p < 0.05)). Subsequent simple effects tests demonstrated that FLX only reduced the immobility time in CD-1 and C57BL/6 mice at higher doses (5-20 mg/kg) (Fig. 3b, c) . In contrast, FLX reduced the immobility time in DBA and BALB/c mice at a lower threshold (2.5-20 mg/kg) (Fig. 3d, e) .
No strain differences in tissue mass in each hippocampal subregion
No significant interaction between hippocampal subregion and strain on tissue mass was detected by two-way ANOVA (F 6,93 = 1.84, p > 0.05; n = 7/group). For each mouse strain, the three hippocamal subregions had a similar tissue mass (Hippocampal subregion effect: F 2,93 = 2.10, p > 0.05). No differences in tissue mass were found in any of the hippocampal subregions among the four mouse strains (Strain effect: F 3,93 = 1.96, p > 0.05) (Fig. 4 ).
Strain differences in 5-HTT protein expression in each hippocampal subregion
The 5-HTT protein levels measured in the hippocampus were shown in Table 1 . No significant two-way interaction was detected between hippocampal subregion and strain (F 6,93 = 3.19, p > 0.05; n = 7/group). For each mouse strain, similar 5-HTT protein levels were found between CA1, CA3, and DG subregions (Hippocampal subregion effect: F 2,93 = 2.37, p > 0.05). However, 5-HTT protein levels in the hippocampus exhibited a significant Strain effect (F 3,93 = 9.84, p < 0.05). Subsequent simple effects tests indicated that DBA mice had the highest level of 5-HTT protein expression in all three hippocampal subregions, followed by BALB/c, which were both higher than the expression levels found in CD-1 and C57BL/6 mice ( Fig. 5 ).
Strain differences in synaptosomal 5-HT uptake in each hippocampal subregion
The 5-HTT protein level measured by Western Blot reflects the total protein expression including both the membrane-bound 5-HTT and the intracellular 5-HTT, which are indistinguishable in this essay. Therefore, the method cannot evaluate the 5-HT uptake mediated by the membrane-bound 5-HTT. In contrast, the synaptosomal preparation preserves viable neuronal cell membrane, which contains a functional membrane-bound 5-HTT and an active metabolic environment inside (Gylys et al., 2000) . Hence, synaptosomes allow for the study of 5-HT uptake and its regulation of the membranebound 5-HTT (Ansah et al., 2003; Zhu et al., 2010; Hagan et al., 2012) . Since strain differences in the total 5-HTT protein expression were found in the hippocampus (Fig. 5) , we used synaptosomal 5-HT uptake to further investigate whether alterations in the membrane-bound portion of the hippocampal 5-HTT had contributed to the overall strain differences in total protein level. For synaptosomal 5-HTT, two parameters of 5-HT uptake, V max and K m , were determined by curve-fitting the Hippocampal subregions, CA1, CA3, DG, were individually dissected out and weighed (n = 7). Two-way ANOVA did not find any differences in tissue mass in any hippocampal subregion among the four mouse strains.
data to the Michaelis-Menten equation as previously described (Tang et al., 2014) . Values of both parameters are shown in Table 2 . For V max , there was no interaction detected between hippocampal subregion and strain (F 6,93 = 2.63, p > 0.05; n = 7/group), only a significant Strain effect was found (F 3,93 = 11.08, p < 0.05). Subsequent simple effects tests indicated that DBA mice had higher V max in the CA1 and DG subregions compared to CD-1 and C57BL/6 mice, and in the CA3 subregion compared to CD-1, C57BL/6 or BALB/c mice. Similarly, there was no interaction detected for K m by two-way ANOVA, only a significant Strain effect was found (F 3,93 = 14.97, p < 0.05). Subsequent simple effects test further indicated that CD-1 and C57BL/6 mice had similar K m values, which were both higher than DBA or BALB/c mice in all three hippocampal subregions.
For synaptosomal 5-HT uptake, V max is positively related to the total number, and K m is negatively related to the uptake efficiency, of the membrane-bound 5-HTT, respectively (Ansah et al., 2003; Zhu et al., 2010; Hagan et al., 2012; Tang et al., 2014) . Our data showed that DBA mice showed a higher V max and a lower K m , indicating that the mice not only had more membrane-bound 5-HTT, but also had higher uptake efficiency in all three hippocampal subregions compared to the other three mouse strains (Fig. 6) .
No correlations between immobility and 5-HTT protein expression
Following the strain differences found in immobility, 5-HTT protein expression, V max and K m of the Values are presented as a ratio of 5-HTT to β-actin levels, and expressed as means ± S.E.M (n = 7). *p < 0.05 vs. CD-1 mice, #p < 0.05 vs. C57BL/6 mice, @ p < 0.05 vs. BALB/c mice, by simple effects analysis after a significant Strain effect in the overall ANOVA. . 5-HTT protein expression of each hippocampal subregion. 5-HTT protein expression was determined by Western Blot and presented as a ratio of 5-HTT to β-actin levels. Strain differences in 5-HTT protein expression were found in each of the hippocampal subregions (n = 7/group). *p < 0.05 vs. CD-1 mice, #p < 0.05 vs. C57BL/6 mice, @p < 0.05 vs. BALB/c mice, by simple effects analysis after a significant Strain effect in the overall ANOVA.
5-HTT
membrane-bound 5-HTT, we investigated whether the behavioral output was associated with hippocampal 5-HTT. Hence, we performed a series of correlation analyses to determine the immobility's relation with hippocampal 5-HTT at baseline, and following FLX treatment. The immobility observed following 10 mg/kg dose of FLX was used to perform the correlation analysis with V max and K m , which was based on the fact that the dose has been more commonly reported to provide effective antidepressant effect in mice compared to the other four doses of FLX used (Ducottet et al., 2003; Isingrini et al., 2012; Tang et al., 2013) . The r 2 values derived from the correlation analysis were reported in Table 3 . Pearson tests did not find any significant correlations of the baseline immobility times detected in either the FST or the TST, with 5-HTT protein expression in any hippocampal subregion at baseline and following the 10 mg/kg FLX administration.
Correlations of immobility with V max , and K m in the hippocampus
Pearson tests indicated significant correlations between the baseline immobility time and V max in the DG subregion. The r 2 values found in the CA1 and CA3 subregions were in the range 0.7-0.89 (see Table 3 ), slightly lower than 0.9 which is a commonly used threshold for determining statistical significant (Fig. 7a) . Interestingly, we found highly significant correlations between the baseline immobility time and K m in all three hippocampal subregions (Fig. 7b) . Furthermore, similar significant correlations were detected between immobility time and K m , or between immobility time and V max , following the FLX administration (Fig. 8 ).
Discussion
Consistent with previous studies, we found significant mouse strain differences in baseline immobility in the FST and the TST and strain differences in the immobility responses to FLX. In both the FST and the TST, DBA and BALB/c mice exhibited shorter baseline immobility time and were more sensitive to FLX than CD-1 and C57BL/6 mice. The key finding of this study is that the four mouse strains showed distinct levels of 5-HTT protein expression and synaptosomal 5-HT uptake in the hippocampus. DBA and BALB/c mice had higher total 5-HTT protein expression, increased number of the membranebound 5-HTT (i.e. higher V max ), and enhanced uptake efficiency of the membrane-bound 5-HTT (i.e. lower K m ) compared to CD-1 and C57BL/6 mice. Further analyses indicated that the higher 5-HT uptake capacity of the membrane-bound 5-HTT in the hippocampus was correlated with shorter baseline immobility time and higher sensitivity to FLX. These results suggest that differences in hippocampal 5-HTT protein expression and function contribute to strain differences in the FST and the TST, and to the responses to antidepressant medication. FST and TST are based on the observation that inescapable aversive stimuli lead to immobile posturing in mice following initial escape-oriented movements, such as when mice are hung by their tails or placed in a confined container of water. The immobility reflects a behavioral despair, a core endophenotype of clinical depression. Most importantly, acute antidepressant treatments reduce the duration of immobility in both tests; therefore, they have been mainly used to screen for new agents with potential antidepressant activity. Although the two tests have similar constructs and often offer converging data on a potential antidepressant, there are still some inherent limitations. For example, FST induces hypothermia as a by-product, which is contrary to the hyperthermia induced by most acute stressors (Liu et al., 2003) . TST, on the other hand, has been shown unsuitable for C57BL/6 mice, one of the most commonly used mouse strains, due to their tendency to climb their tails Cryan et al., 2003) . Hence, it is a better approach if the two tests are both performed, which can complement each other to reveal baseline immobility and responses to a specific antidepressant.
In the present study, we observed strain differences in baseline immobility in the FST and the TST. DBA and BALB/c mice had shorter immobility than C57BL/6 and CD-1 mice. To rule out the possibility that the shorter immobility maybe caused by lower locomotor activity at baseline, we first measured the baseline locomotor activity and did not find any differences among the four strains. Hence, we conclude that baseline immobility is a behavioral phenotype independent of locomotor activity.
Strain differences in sensitivity to FLX were observed in the FST and the TST as well. DBA and BALB/c mice (n = 7). *p < 0.05 vs. CD-1 mice, # p < 0.05 vs. C57BL/6 mice, @p < 0.05 vs. BALB/c mice, by simple effects analysis after a significant strain effect in the overall ANOVA.
responded to FLX at the lowest dose of 1.25 mg/kg, and C57BL/6 and CD-1 mice only responded to FLX at higher doses of 5 and 10 mg/kg, respectively. If FLX affects locomotor activity besides its anti-immobility effect in the FST and the TST, then the two distinct effects of FLX on motor activity may be difficult to differentiate. So, we measured the locomotor activity following FLX treatment given at all five different doses, and did not observe any changes in the locomotor activity compared to their saline-treated controls in each strain. This indicates that locomotor activity is not related to the anti-immobility effect elicited by FLX in the FST and the TST. Our findings of the strain differences in baseline immobility are consistent with the observations by Sugimoto et al. (2008 Sugimoto et al. ( , 2011 and Lucki et al. (2001) in the FST, and with Ripoll et al. (2003) and Liu et al. (2003) in the TST, except that the baseline immobility we observed in DBA and BALB/c mice (50-70 s) were shorter than those reported (90-270 s), which could be due to procedural differences. However, David et al. (2003) reported no differences in baseline immobility between C57BL/6 and DBA mice in the FST. Their study and ours use similar methodology in terms of animals' sex, age and prior exposure to the behavioral test. One primary difference between these studies is the housing conditions. In their study, mice were housed in groups of 20 per cage for at least 1 wk prior to testing. Group housing can cause social distress associated with hierarchy formation, which might influence immobility responses of these mice in the FST (Audet and Anisman, 2010; Audet et al., 2011; McQuaid et al., 2012 McQuaid et al., , 2013a . In contrast, all mice in our study were individually housed for at least 2 wk prior to behavioral tests. Interestingly Bai et al. (2001) reported a large difference in baseline immobility time between the FST and the TST in NIH-Swiss mice. However, we did not find any differences between the two tests in any of the four mouse strains tested, suggesting that the reported difference in NIH-Swiss mice may be a strain-specific phenotype.
Our findings of the strain differences in sensitivity to FLX are generally consistent with the work by Lucki et al. (2001) in the FST, showing a higher sensitivity to FLX-induced reduction in immobility in DBA and BALB/c mice. However, there are differences in the threshold doses of FLX capable of lowering the immobility. Lucki et al., reported that 5-20 mg/kg was an effective dose range for DBA mice, whereas only 10 mg/kg was effective for BABL/c mice. Our study showed a wider effective dose range of 2.5-20 mg/kg for the two mouse strains. Group housing vs. single housing could have factored into these minor discrepancies as well.
Besides our study, we are not aware of any other studies that evaluated FLX-induced immobility responses in either the FST or the TST. However, the effects of other common antidepressants, such as paroxetine, citalopram, fluvoxamine, imipramine and bupropion, on immobility responses were reported in the mouse strains used in our study. It was observed in most studies that DBA and BALB/c mice were more sensitive compared to CD-1 and C57/BL/6 mice in either the FST or the TST (Cryan et al., 2005; Petit-Demouliere et al., 2005; Sugimoto et al., 2008 Sugimoto et al., , 2011 . However, David et al. (2003) found C57BL/6 mice were more sensitive to the antidepressants than DBA mice instead. They also observed altered locomotion at different doses following antidepressant treatments, which may confound the interpretation of the antidepressant-induced immobility responses in the FST in addition to the potential effect of the group housing used in their study. In summary, immobility responses to antidepressants may vary with mice' age, sex, and housing conditions, including the duration of group housing and the number of mice per cage, prior exposure to drugs or behavioral tests, as well as common variations in experimental procedures and genotype.
During the behavioral testing, two issues came to our attention. One is that DBA mice exhibited a baseline immobility of only 40-50 s, which was further shortened following FLX treatment. At 20 mg/kg of FLX, the highest dose tested, the immobility time was decreased to less than 10 s. It may imply that it is impossible to observe additional anti-immobility effect at higher doses, which could limit its use in screening for a wide range of antidepressant effects during drug discovery. The second is that we did observe that some C57BL/6 mice climbed their tails in the TST, and those mice were excluded from data analysis. Among the mouse strains tested, CD-1 mice responded well to FLX in both the FST and the TST and did not exhibit the problems observed in DBA and C57BL/6 mice. Thus, CD-1 mice seem to be a good candidate mouse strain for behavioral tests and psychopharmacological studies. In summary, caution should be exercised in selection of a mouse strain and in interpretation of data obtained from different strains.
In the present study, we performed correlation analysis of immobility with 5-HTT protein level, V max and K m of 5-HT uptake, in each of the hippocampal subregions. Similar patterns of correlations were found at baseline and following FLX treatment. Immobility was significantly correlated with V max and K m , but not with 5-HTT protein expression, suggesting that the membrane-bound 5-HTT was associated with the strain differences in immobility. Furthermore, the correlation analysis revealed that the number and the uptake efficiency of the hippocampal membrane-bound 5-HTT were both key factors contributing to the differences in immobility between Hippocampal 5-HTT and mouse strain differences 1745 strains at baseline and following FLX treatment. In addition, we observed a subregion-specificity, i.e. immobility times correlated with V max mainly in the DG subregion, but not in the CA1 and the CA3 subregions. In contrast, there were significant correlations with K m found in all three hippocampal subregions. Similar hippocampal subregion-specificity was previously reported in the regulation of emotional responses, learning and memory, and the hypothalamic-pituitary-adrenal axis regulated responses (Herman et al., 1995; Moser and Moser, 1998; Pitkanen et al., 2000) . More recently, DG-specific neurogenesis is thought to mediate the action of antidepressants (Santarelli et al., 2003; Jiang et al., 2005; Airan et al., 2007) . However, the mechanisms underlying the subregion-specificity are still not clear. Our results suggest that higher amount of or more efficient All data used for the correlation analyses were averaged data (n = 7/group). Immobility times in the forced swim test and the tail suspension test were correlated with V max (a) in the DG subregion, and with K m (b) in all three hippocampal subregions.
membrane-bound 5-HTT in the hippocampus may underlie the lower baseline immobility and greater sensitivity to acute FLX treatment in the FST and the TST. Sugimoto et al. (2008 Sugimoto et al. ( , 2011 reported that DBA and BALB/c mice with shorter duration of baseline immobility and greater sensitivity to fluvoxamine and paroxetine in the FST showed lower levels of B max (the total binding sites) in 5-HTT binding kinetics compared to C57BL/6, ICR and ddY mouse strains. The discrepancy between their work and ours may be due to the difference in the brain region from which 5-HTT activity was analyzed. Sugimoto et al. (2008) used a whole brain preparation, whereas our studies were done in the hippocampus, a discrete brain region that has been clearly shown to be involved in the pathophysiology of depression. Since it is impossible to predict changes in hippocampal 5-HTT binding based on the results of the whole brain, relevant comparisons cannot be made. Our studies are limited to data obtained from the hippocampus using Western Blot analysis and synaptosomal preparations. However, their binding study highlight the need in our next experiment to measure [ 3 H]-paroxetine specific binding of the membrane-bound portion of 5-HTT in the three hippocampal subregions to further corroborate our main findings that the membrane-bound 5-HTT is different between mouse strains.
In conclusion, mouse strain differences in baseline immobility and sensitivity to FLX treatment were correlated with V max and K m in the hippocampus, suggesting that the amount and/or the uptake efficiency of the membrane-bound hippocampal 5-HTT may be a significant contributing factor for immobility phenotype. Genetic variations appear to be responsible for the mouse strain differences in hippocampal 5-HTT levels and their uptake activities. These differences may help explain some of the discrepancies in reports that use these strains of mice to examine the role of 5-HT in mouse models of depression. Future studies should investigate additional neural substrates and molecular mechanisms underlying strain variations in mouse models of depression in order to help identify genetic predispositions to this disease in the human.
